Market Insights

As per recent research by MarkNtel Advisors, The Global Plasma Fractionation Market is estimated to grow at a CAGR of around 7.1% during the forecast period, i.e., 2024-30.

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html

Global Plasma Fractionation Market Driver:

Escalating Geriatric Population Driving the Demand for Plasma-derived Therapies – Globally, the surging geriatric population has resulted in a substantial boost in the incidences of diseases like immunodeficiency, neurological disorders, etc., which require plasma-derived therapies for treatment. The increment in the geriatric population has been attributed to the increasing life expectancy of the elderly population in various countries like China, Japan, etc., as a result of their improved healthcare infrastructure. Consequently, as the number of geriatric patients has been increasing, there has been an enhanced demand for plasma-derived therapeutic products, particularly immunoglobulins and coagulation factors during historical years.

Further, in response to this growing demand on a global scale, companies specializing in plasma fractionation have proactively started investing in expanding their plasma therapy manufacturing facilities. Such strategic initiatives by companies across the world position them to better address the increasing need for improved treatment, ultimately contributing to positive growth of the Plasma Fractionation Market.

Market Segmentation and Consumer Behavior:

  • By Product
    • Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
      • Intravenous Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
      • Subcutaneous Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
      • Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.) - Market Size & Forecast 2019-2030, (USD Million)
    • Coagulation Factors- Market Size & Forecast 2019-2030, (USD Million)
      • Factor VIII- Market Size & Forecast 2019-2030, (USD Million)
      • Factor IX- Market Size & Forecast 2019-2030, (USD Million)
      • Von Willebrand Factor (vWF) - Market Size & Forecast 2019-2030, (USD Million)
      • Prothrombin Complex Concentrates- Market Size & Forecast 2019-2030, (USD Million)
      • Fibrinogen Concentrates- Market Size & Forecast 2019-2030, (USD Million)
      • Factor XIII- Market Size & Forecast 2019-2030, (USD Million)
      • Others (Factor VIIa, Factor XI, etc.)- Market Size & Forecast 2019-2030, (USD Million)
    • Albumin- Market Size & Forecast 2019-2030, (USD Million)
    • Protease Inhibitor- Market Size & Forecast 2019-2030, (USD Million)
    • Others (Plasminogen, Antithrombin III, etc.) - Market Size & Forecast 2019-2030, (USD Million)
  • By Application
    • Neurology- Market Size & Forecast 2019-2030, (USD Million)
    • Immunology- Market Size & Forecast 2019-2030, (USD Million)
    • Hematology- Market Size & Forecast 2019-2030, (USD Million)
    • Critical Care- Market Size & Forecast 2019-2030, (USD Million)
    • Pulmonology- Market Size & Forecast 2019-2030, (USD Million)
    • Rheumatology- Market Size & Forecast 2019-2030, (USD Million)
    • Others (Oncology, Pediatrics, etc.) - Market Size & Forecast 2019-2030, (USD Million)
  • By End User
    • Hospitals - Market Size & Forecast 2019-2030, (USD Million)
    • Specialty Clinics- Market Size & Forecast 2019-2030, (USD Million)
    • Research Facilities - Market Size & Forecast 2019-2030, (USD Million)

Read Full Report: https://www.marknteladvisors.com/research-library/plasma-fractionation-market.html

Plasma Fractionation Market Geographical Analysis:

By Region:

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Key Players and Competitive Strategies in the Plasma Fractionation Market

Several prominent players dominate the Plasma Fractionation Market, including:

  • Biotest A.G.
  • Octapharma A.G.
  • Adma Biologics
  • Aegros
  • CSL Limited
  • Grifols S.A.
  • Kedrion Biopharma Inc.
  • Bio Products Laboratory Ltd
  • Takeda Pharmaceuticals
  • Emergent Bio solutions
  • Intas Pharmaceutical
  • Plasma Gen Biosciences
  • S K Plasma
  • Australian Red Cross Lifeblood

Report Delivery - MarkNtel Advisors offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

1.What factors are driving the Plasma Fractionation Market growth?

2.How is the Plasma Fractionation Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Plasma Fractionation Market?

4.What is the current size of the Plasma Fractionation Market, and how is it projected to change in the future?

5.What is the future outlook for the Plasma Fractionation Market in terms of technological advancements and market expansion?

Request Customization - https://www.marknteladvisors.com/query/request-customization/plasma-fractionation-market.html

Read Blog:

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India